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Abstract
Unexpandable lung is theinability of the lung to expand to thechest wall allowing for normal visceral and
parietal pleural apposition. It is the direct result of either pleural disease, endobronchial obstruction
resultinginlobarcollapse,orchronicatelectasis.Unexpandablelungoccurringasaconsequenceofactive
or remote pleural disease may present as a post-thoracentesis hydropneumothorax or an effusion that
cannot be completely drained because of the development of anterior chest pain. Pleural manometry is
useful for identifying unexpandable lung during initial pleural drainage. Unexpandable lung occurring as a
consequence of active or remote pleural disease may be separated into two distinct clinical entities
termed trapped lung and lung entrapment. Trapped lung is a diagnosis proper and is caused by the
formation of a fibrous visceral pleural peel (in the absence of malignancy or active pleural inflammation).
The mechanical effect of the pleural peel constitutes the primary clinical problem. Lung entrapment may
result from a visceral pleural peel secondary to active pleural inflammation, infection, or malignancy. In
these cases, the underlying malignant or inflammatory condition is the primary clinical problem, which
may or may not be complicated by unexpandable lung due to visceral pleural involvement. The
recognition of trapped lung and lung entrapment as related, but distinct, clinical entities has direct
consequences on clinical management. In our practice, pleural manometry is routinely performed during
therapeutic thoracentesis and is useful for identification of unexpandable lung and has allowed us to
understand the mechanisms surrounding a post-thoracentesis pneumothorax.
Introduction and context
Unexpandable lung is a mechanical complication result-
ing in the inability of the lung to expand to the chest wall.
In clinical practice, an unexpandable lung may be due to
either the presence of pleural disease, endobronchial
obstruction resulting in lobar collapse, or chronic atelec-
tasis [1]. Unexpandable lung due to pleural disease is
clinicallyobviouswhenapneumothoraxdevelopsfollow-
ing thoracentesis or when chest pain develops during or
following pleural fluid removal. However, with the
application of pleural manometry, all cases of unexpand-
able lung can be accurately diagnosed.
Recent advances
The term trapped lung has traditionally been used
interchangeably to describe an unexpandable lung
occurring from either active or remote pleural disease.
Currently, we have adopted a more strict definition for
a trapped lung. Trapped lung is the sequela of remote
pleural space inflammation resulting in the develop-
ment of a mature, fibrous membrane that impedes lung
expansion during fluid removal (Figure 1). In other
words, trapped lung can be considered to be defective
pleural healing once inflammation in the pleural space
has resolved. In contrast, lung entrapment is considered a
complication of active pleural inflammation, malignancy,
or hemothorax. Identifying active pleural inflammation
or malignancy is critical in differentiating lung entrap-
ment from trapped lung. Clinical conditions associated
with the development of lung entrapment include
coronary artery bypass graft surgery, post cardiac injury
syndrome, empyema/complicated parapneumonic
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pleurisy [1-3].
In the setting of lung entrapment, chest radiography may
reveal contra-lateral mediastinal shift. Pleural fluid
analysis is typically exudative by both protein and lactate
dehydrogenase (LDH) criteria; however, discordant
protein and LDH exudates can occur as the inflammatory
process is resolving. An increased total nucleated cell
count with either a lymphocyte or neutrophil predomi-
nance is observed depending upon the etiology of the
lung entrapment.
Treatment of lung entrapment is dictated by the under-
lying process that resulted in the unexpandable lung.
Rapid evacuation of a hemothorax or prompt antibiotic
therapy for pneumonia with parapneumonic effusion
usually prevents the development of trapped lung follow-
ingtheseconditions.Ifdysfunctionalpleuralspacehealing
occurs, the end result is a trapped lung. However, in the
setting of malignancy, the presence of lung entrapment
will significantly decrease the success of pleurodesis [2].
Pleural manometry remains the method of choice for
detecting unexpandable lung [3-9]. Standardization of
pleural manometry was described by Doelken and
colleagues[4].Themeasurementofpleuralliquidpressure
can be performed either by using a simple water column
manometer or with elaborate electronic, physiologic
systemsconnectedtoastandardhemodynamictransducer
[4].Asimple,over-dampedwatermanometercanbeeasily
employed by all physicians performing therapeutic
thoracentesis.
Measuring pleural liquid pressure may improve patient
safety and reduce the development of re-expansion
pulmonary edema (RPE). RPE is a well-recognized
complication of therapeutic thoracentesis and is char-
acterized by the development of unilateral pulmonary
edema in a lung re-inflated rapidly after a period of
collapse from either a pleural effusion or pneumothorax.
The clinical presentation of RPE ranges from relatively
benign to life-threatening. Historical recommendations
to prevent RPE suggest that fluid removal should not
exceed 1-1.5 liters at a single sitting. Current recommen-
dations to terminate thoracentesis include the develop-
ment of excessively negative pleural pressures or the
development of chest pain [3-9].
In addition to providing improved patient safety, pleural
manometry is useful for the diagnosis of an unexpand-
able lung at the bedside and for predicting pleurodesis
success. Pressure measured with a catheter residing in a
pleural effusion is representative of the actual pressure at
that level of the effusion. Changes in pressure during
respiration represent pressure changes throughout the
effusion. The pressure measured is reflective of the recoil
pressures of the lung and chest wall and the vertical
extent of the pleural effusion. The measured pressure
changes are reflective of the changes of the recoil forces,
and pleural space elastance (PEL) can be calculated (PEL =
change in pleural liquid pressure in cm H2O per liter of
fluid removed).
Three pressure/volume curves are typically encountered.
The pressure/volume curve of a patient with an expand-
able lung is monophasic with a normal elastance,
defined as a PEL ≤14.5 cm H2O/L [3,5,8-10]. Terminal
negative pressure deflections are seen when minimal
amounts of pleural fluid remain and are attributed to
local deformation forces around the catheter. The
pressure/volume curve of a patient with a trapped lung
is monophasic with an elevated PEL >14.5 cm H2O/L.
Finally, a biphasic pressure/volume curve demonstrates a
normal PEL prior to an inflection point and a high PEL in
the terminal portion of the pressure/volume curve. The
presence of a biphasic pressure/volume curve is consis-
tent with lung entrapment assuming that the clinical
history and pleural fluid analysis supports a finding of
malignancy, infection, or inflammation (Figure 2).
Figure 1. Computed tomography scan showing abnormal visceral
pleural thickening
This is an air-contrast chest computed tomography scan showing abnormal
visceral pleural thickening (arrows) in the setting of lung entrapment from a
resolving hemothorax.
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Unexpandable lung resulting from an endobronchial
obstruction is managed by removing either the tumor or
foreign body impeding normal lung expansion. In the
setting of chronic atelectasis, the lung may re-expand
over several days as long as the underlying lung
parenchyma is devoid of significant fibrosis. Most
patients with trapped lung are asymptomatic; however,
it may be the cause of significant restriction and dyspnea.
In this case, the only effective therapy would be surgical
decortication only after other causes of dyspnea are
excluded. In contrast, the focus of initial treatment for
lung entrapment is dependent on the nature of the active
process. For example, antibiotics and pleural drainage
are required for treating a complicated parapneumonic
effusion and pleural drainage is required for hemothorax
evacuation. In contrast, lung entrapment in the setting of
a malignant pleural effusion can only be successfully
managed with a chronic, indwelling pleural catheter.
Finally, we have obtained better insights into the
mechanism by which a pneumothorax occurs following
ultrasound-guided thoracentesis and why chest tubes
can be safely removed despite the presence of an air
leak or pneumothorax. Pneumothorax following
ultrasound-guided thoracentesis is a rare complication.
The development of pneumothorax is commonly due to
the drainage itself and is not related to direct puncture of
the visceral pleural or to the introduction of air into
the pleural space via the drainage system. The pathophy-
siology of drainage-related pneumothorax is the result
of transient, pressure-dependent, parenchymal-pleural
fistulas, which develop as a consequence of an existing
unexpandable lung unable to conform to the shape of the
chest wall with fluid removal [11]. This pathophysiologic
mechanism is further supported by the safety data
reported by Cerfolio and colleagues [12] on removing
chest tubes in post-lobectomy patients despite the
presence of a persistent air leak or a pneumothorax.
Abbreviations
LDH, lactate dehydrogenase; PEL, pleural space elastance;
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Figure 2. A normal elastance curve, a biphasic curve (malig-
nancy), and a curve from a trapped lung (remote complicated
parapneumonic effusion)
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Three pressure/volume curves are shown. The curve denoted by the solid
circles represents a monophasic pressure/volume curve with normal pleural
elastance predicting normal lung expansion. This was a case of hepatic
hydrothorax. The curve denoted by open circles is a biphasic pressure/
volume curve from a patient with malignant lung entrapment. Note that the
calculated pleural space elastance (PEL) prior to the inflection point is
normal, while the calculated PEL after the inflection point is increased,
predicting abnormal lung expansion. This was a case of a patient with a
malignant pleural effusion. The curve denoted by the solid triangles
represents a monophasic pressure/volume curve with increased PEL. This
shows a trapped lung resulting from a remote parapneumonic effusion.
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